Dechra Pharmaceuticals (DPH) Pharma and Biotech Sector

  • Latest quote

    2,014.00p (mid)

  • Current Change (%)

    -2.14%

  • Price

    Bid: 2,006.00p

    Offer: 2,008.00p

  • Today

    High: 2,062.00p

    Low: 1,992.00p

  • This year

    High: 3,168.00p

    Low: 1,970.00p

  • Information

    Volume: 217,678

    Market Cap: £2048.16M


Dechra Pharmaceuticals Overview

Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.

Stockomendation On Seedrs

Dechra Pharmaceuticals RNS Feed

Title Release date
Total Voting Rights 13:34 - October 31, 2018
Director/PDMR Shareholding 14:20 - October 26, 2018
Director/PDMR Shareholding 15:17 - October 24, 2018
Holding(s) in Company 15:00 - October 24, 2018
Director/PDMR Shareholding 09:42 - October 23, 2018
Result of AGM 13:37 - October 19, 2018
Dechra acquire Laboratorios Vencofarma do Brasil 07:01 - October 19, 2018
AGM Trading Update 07:00 - October 19, 2018
Holding(s) in Company 13:50 - October 18, 2018
Holding(s) in Company 10:41 - October 11, 2018
Bolt -on Acquisition 07:00 - October 8, 2018
Additional Listing 07:00 - October 8, 2018
Holding(s) in Company 09:51 - October 5, 2018
Holding(s) in Company 09:51 - October 5, 2018
Holding(s) in Company 09:43 - October 3, 2018
Stockomendation On Seedrs

NOTE: This is based on 26 open tips for this company


Total Number of Share tips :

37

View all Dechra Pharmaceuticals Tips



Daily share tips delivered straight to your pc, tablet & mobile

Join Free Today